Walleye Trading LLC Revance Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $40,920 - $81,928	8,800 Added 44.67%	28,500 $140,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $111,551 - $215,040	19,200 Added 3840.0%	19,700 $173,000
Q3 2023 Nov 14, 2023	SELL	$11.47 - $25.07 $22,940 - $50,140	-2,000 Reduced 80.0%	500 $5,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $54,340 - $82,742	2,200 Added 733.33%	2,500 $63,000
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $317,628 - $610,171	-17,300 Reduced 98.3%	300 $9,000
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $304,112 - $508,956	16,600 Added 1660.0%	17,600 $324,000
Q3 2022 Nov 14, 2022	SELL	$14.33 - $28.47 $153,331 - $304,629	-10,700 Reduced 91.45%	1,000 $27,000
Q2 2022 Aug 08, 2022	BUY	$11.52 - $20.4 $102,528 - $181,560	8,900 Added 317.86%	11,700 $162,000
Q1 2022 May 16, 2022	SELL	$12.36 - $20.31 $181,692 - $298,557	-14,700 Reduced 84.0%	2,800 $55,000
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $186,900 - $418,050	15,000 Added 600.0%	17,500 $286,000
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $837,850 - $1.08 Million	-32,500 Reduced 92.86%	2,500 $70,000
Q2 2021 Aug 16, 2021	BUY	$26.8 - $31.84 $938,000 - $1.11 Million	35,000 New	35,000 $1.04 Million
Q1 2021 May 17, 2021	SELL	$24.03 - $29.97 $1.53 Million - $1.91 Million	-63,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.41 - $28.34 $1.49 Million - $1.81 Million	63,700 Added 63700.0%	63,800 $1.81 Million
Q3 2020 Nov 16, 2020	BUY	$23.23 - $34.3 $2,323 - $3,429	100 New	100 $3,000

231

83.2M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.